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Abstract
Introduction: There are more than 18000 thalassemia patients in Iran. In a current study, 
a high rate of mortality in these patients due to heart failure, is shown. Main factors for 
evaluating this disorder in thalassemia patients were their electrocardiograms (EKGs) and 
Serum Ferritin Levels (SFLs).
Methods: We studied the cardiac function in 91 patients (73 major and 18 intermediate 
thalassemia patients) treated in Zafar Thalassemia Center, of whom 35 (38.45%) were 
male and 56 (61.55%) were female. The Factors in this study contains: EKGs, mean 
annual serum ferritin (at least, three SFL had been recorded in each patient treatment file 
in 2009), mean annual hemoglobin (Hb) levels and mean annual hematocrit (Hct) levels 
(average, 12 recorded hematocrit levels during 2009).
Results: Our findings have shown that Q-T interval did not correlate with ferritin (r = 
0.05, P > 0.05). In both patients with LVH and without LVH, there was no significant 
difference in SFL (P > 0.05). Although, the mean rate among the thalassemia patients was 
85.34 ± 12.91, it did not correlate significantly with QRS duration and P-R Interval (r = 
-0.08, P > 0.05). In addition, ferritin did not correlate significantly with QRS duration and 
P-R Interval (r = 0.1, r = 0.05 and P > 0.05, P > 0.05). Furthermore, there was no difference 
in SFL in patients with normal cardiac axis and those with cardiac axis deviation.
Conclusion: There is no correlation between SFL and variations in EKG. Although EKG 
is an available method for checking cardiac function in thalassemic patients, especially 
in developing countries, physicians cannot rely on it for diagnosis or prognosis of 
cardiac failure in thalassemia patients. Therefore, other methods such as MRIT2* and 
Echocardiography are suggested to be used periodically in order to check the cardiac 
function in thalassemia patients.
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INTRODUCTION
Thalassemia is a prevalent inherited blood disorder. According 
to Iranian Thalassemia Society, more than 18000 patients had 
been registered in Iran by 2006. During two last decades, mean 
age of the patients has increased due to the better care. Howev-
er, like other parts of the world, cardiac failure is the most cru-
cial problem among young and teenagers with thalassemia [1, 
2]. Hadaegh F. reported that 21.8% (22.3% women and 18.8% 
men) of thalassemia patients in Tehran (capital of Iran) are af-
fected by different levels of cardiac failure [3]. Therefore, it is a 
prioritized duty of care groups to check cardiac function in all 
patients in order to prevent cardiac failure. The main cardiac 
abnormalities reported in patients with thalassemia are iron 
overload and left ventricular systolic and diastolic dysfunction, 
pulmonary hypertension, valvulopathies, arrhythmias, and 
pericarditis [2]. Its prevalence varies according to the type of 
thalassemia. Even though thalassemia intermedia patients re-
quire less transfusions than thalassemia major patients, they 
are still at risk of cardiac complications. With the introduction 
of new technologies, such as cardiac magnetic resonance T2*, 
the early detection of cardiac iron overload and associated 
cardiac dysfunction can be presently possible. In addition, an 
EKG and a chest radiograph (X-Ray) should also be obtained. 
Two-dimensional echocardiography helps differentiate systol-
ic from diastolic dysfunction. However, MRIT2* is not acces-
sible in all centers where thalassemia is of high prevalence and 
Echocardiography is an expensive method which can be con-
ducted merely with an all - and - out expert [2, 4-6].
Hence, it is not possible to follow thalassemia patients relying 
on both methods in all parts of developing countries like Iran. 
As a result, EKG is used to determine the reliability of prognos-
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METHODS
In this study, the heart function in 91 patients (73 major 
thalassemia and 18 intermedia) treated in Zafar Thalassemia 
Center in Tehran, was studied. The patients were between 15 
and 45 years old; 35 (38.45%) of these patients were male 
and 56 (61.55%) were female. EKG of patients was consid-
ered as well as the mean level of annual serum ferritin (at least 
three SFLs had been recorded in each patient treatment file 
in 2009), mean of annual hemoglobin and hematocrit lev-
els (on average, 12 records of the results of hematocrit tests 
during 2009). Serum ferritin and hematocrit levels have been 
found in the patient’s clinical files which are maintained in 
the clinic. A cardiologist has tested patients’ heart function 
using EKG.
Figure 1: PCorrelation Between Ferritin and P-R Interval
Figure 1: Correlation Between Ferritin and QRS Duration
RESULTS
Our findings show that Q-T interval did not correlate with 
ferritin (r = 0.5, P > 0.05). Both in patients with LVH and 
without LVH, there was no significant difference in serum 
ferritin level (P > 0.05). Although the mean rate among the 
thalassemic patients was 85.34 ± 12.91, it did not correlate 
significantly with serum ferritin level (r = -0.08, P > 0.05). 
In addition, ferritin did not correlate significantly with QRS 
Duration and P-R Interval (r = 0.1, r = 0.05 and P > 0.05, P 
> 0.05) (Figs 1 and 2). Furthermore, there was no difference 
between serum ferritin level in patients having normal axis 
and patient with axis deviation.
DISCUSSION
There is no correlation with serum ferritin level and contents 
of Electrocardiogram (EKG). Albeit EKG is an available and 
inexpensive method, especially in developing regions, to 
check patient’s heart function physicians cannot find a logical 
correlation between EKG and ferritin to show whether the 
increase of level of ferritin could affect patient EKG. Further-
more, we are not able to correlate EKG to levels of hemato-
crit. Our findings prove that new methods like MRIT2* and 
Electrocardiography play a vital role in preventing and dis-
criminating heart problems in thalassemia patients. At least, 
in case of patients with thalassemia, EKG cannot be reliable 
to diagnose the dysfunction in heart. Health care decision 
makers should be responsible to furnish new methods and 
make them available and free of charge for all thalassemics.
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